Prabhudas Lilladher's research report on Apollo Hospitals Enterprise
Apollo hospitals enterprise’s (APHS) 100% subsidiary “Apollo HealthCo” (AHL) has entered into agreement to raise equity capital of Rs. 24.75bn ($300mn) from Advent International (Advent) for 16.8% stake. In addition, AHL has also proposed integration of promoter group entity Keimed Pvt Ltd (Keimed) into AHL in phased manner. This will create leading integrated pharmacy distribution business complemented by fast growing omnichannel digital health business. While stake sale of AHL to Advent was done below our estimates by $0.8- 0.9bn; likely merger of Keimed with AHL is a positive step and removes overhang of any leakage.
Outlook
Further mgmt. guidance of Rs17.5-20bn EBITDA of merged entity by FY27 provides comfort. Maintain Buy rating with TP of Rs7,050/share.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
